Carisoprodol
From Psychology Wiki
Community portal · Tasks to do · News · Help
Clinical · Educational · Ind&Org · Other fields · Professional · Transpersonal · World
Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Personality | Philosophy | Research Methods | Social | Statistics
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology
|
Image:Carisoprodol-2D-skeletal.png | |
| [2-methyl-2-(1-methylethylcarbamoyloxymethyl) pentyl]aminomethanoate IUPAC name | |
| CAS number 78-44-4 | ATC code |
| PubChem 2576 | DrugBank APRD00417 |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 260.33 g/mol |
| Bioavailability | |
| Metabolism | Hepatic (CYP2C19-mediated) |
| Elimination half-life | 8 hours |
| Excretion | Renal |
| Pregnancy category | |
| Legal status | Scheduled in some U.S. states |
| Routes of administration | Oral |
Carisoprodol is a skeletal muscle relaxant whose active metabolite is meprobamate. Although several case reports have shown that carisoprodol has abuse potential, it continues to be widely prescribed (not so in the United Kingdom where use of benzodiazepines is preferred). Carisoprodol is a colorless, crystalline powder, having a mild, characteristic odor and a bitter taste. It is slightly soluble in water and freely soluble in alcohol, chloroform and acetone. Its solubility is practically independent of pH. It is marketed in the United States under the brand name Soma, and in the United Kingdom and other countries under the brand name Carisoma.
Contents |
[edit] Chemistry
It is a carbamic acid ester. Carisoprodol is a racemic mixture of two stereoisomers.
[edit] Effects
- Analgesia
- Relief from hypertonia
[edit] Side effects
These are somewhat rare when used at normal doses.
[edit] Pharmacokinetics
Carisoprodol has a rapid, 30 minute onset of action, with the aforementioned effects lasting for approximately 2–6 hours. It is metabolized in the liver via the cytochrome P450 oxidase isozyme CYP2C19, excreted by the kidneys and has an approximate 8 hour half-life.
[edit] References
APhA Drug Information Handbook
[edit] External links
Muscle relaxants (M03) | |
|---|---|
| Peripherally acting (primarily antinicotinic, neuromuscular-blocking drugs) | curare alkaloids (Alcuronium, Dimethyltubocurarine, Tubocurarine) - choline derivatives (Suxamethonium) - other quaternary ammonium compounds (Atracurium, Cisatracurium, Doxacurium chloride, Fazadinium bromide, Gallamine, Hexafluronium, Mivacurium chloride, Pancuronium, Pipecuronium bromide, Rocuronium bromide, Vecuronium) - other (Botulinum toxin) |
| Centrally acting | carbamic acid esters (Phenprobamate, Carisoprodol, Methocarbamol, Styramate, Febarbamate), Baclofen, Chlormezanone, Chlorzoxazone, Cyclobenzaprine, Lorazepam, Mephenesin, Orphenadrine, Phenyramidol, Pridinol, Tetrazepam, Thiocolchicoside, Tizanidine, Tolperisone |
| Directly acting | Dantrolene |
| This page uses content from the English-language version of Wikipedia. The original article was at Carisoprodol. The list of authors can be seen in the page history. As with Psychology Wiki, the text of Wikipedia is available under the GNU Free Documentation License. |
